Back to Search
Start Over
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.
- Source :
-
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2009 Nov 01; Vol. 52 (3), pp. 431-2. - Publication Year :
- 2009
- Subjects :
- Adenine administration & dosage
Adenine pharmacokinetics
Adenine therapeutic use
Anti-HIV Agents administration & dosage
Anti-HIV Agents blood
Anti-HIV Agents therapeutic use
Atazanavir Sulfate
Drug Interactions
Drug Therapy, Combination
Female
History, 17th Century
Humans
Male
Oligopeptides blood
Oligopeptides pharmacokinetics
Organophosphonates pharmacokinetics
Pyridines blood
Pyridines pharmacokinetics
Tenofovir
Adenine analogs & derivatives
HIV Infections drug therapy
Oligopeptides administration & dosage
Oligopeptides therapeutic use
Organophosphonates administration & dosage
Organophosphonates therapeutic use
Pyridines administration & dosage
Pyridines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1944-7884
- Volume :
- 52
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of acquired immune deficiency syndromes (1999)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 19858926
- Full Text :
- https://doi.org/10.1097/QAI.0b013e3181b08f09